Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 15:54 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Lymphocytic B-Leukemia (B-CLL) w/Human IL-2 Gene Modified & Human CD40 Ligand-Expressing Autologous Tumor Cells
NCT00224354 · Baylor College of Medicine · PHASE1 · withdrawn · last registry update 2012-05-21 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
No reason was published
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | The registry record gives no reason | – | Registry record, Baylor College of Medicine |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against IL2RA within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2013-03-21Results posted on the registry: National Cancer Institute (NCI), Cyclophosphamide + Fludarabine (NCT01369875)
- 2012-12-13Results posted on the registry: Masonic Cancer Center, University of Minnesota, aldesleukin + allogeneic large multivalent immunogen vaccine (NCT00726739)
- 2012-11-22Results posted on the registry: M.D. Anderson Cancer Center, Fludarabine + Cyclophosphamide (NCT00698009)
- 2012-11-15Results posted on the registry: National Cancer Institute (NCI), LMB-2 (NCT00077922)
- 2012-10-25Results posted on the registry: National Cancer Institute (NCI), Denileukin diftitox (Ontak) (NCT00117845)
- 2012-10-24Results posted on the registry: National Cancer Institute (NCI), LMB-2 (NCT00080535)
- 2012-10-19Results posted on the registry: The University of Texas Health Science Center at San Antonio, Ontak (NCT00880360)
- 2012-10-11Phase 3 first posted: St. Anna Kinderkrebsforschung, Vincristine + Aldesleukin (NCT01704716)
- 2012-07-16Results posted on the registry: Masonic Cancer Center, University of Minnesota, aldesleukin + cyclophosphamide (NCT00871689)
- 2012-04-18Results posted on the registry: M.D. Anderson Cancer Center, Temozolomide + Velban (NCT00505635)
- 2011-10-17Phase 3 first posted: Hospital Vall d'Hebron, ATeGe-Fresenius (NCT01453218)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision